JP2020527175A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527175A5
JP2020527175A5 JP2020524667A JP2020524667A JP2020527175A5 JP 2020527175 A5 JP2020527175 A5 JP 2020527175A5 JP 2020524667 A JP2020524667 A JP 2020524667A JP 2020524667 A JP2020524667 A JP 2020524667A JP 2020527175 A5 JP2020527175 A5 JP 2020527175A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
haloalkyl
halo
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527175A (ja
JP7067725B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/095973 external-priority patent/WO2019015583A1/en
Publication of JP2020527175A publication Critical patent/JP2020527175A/ja
Publication of JP2020527175A5 publication Critical patent/JP2020527175A5/ja
Application granted granted Critical
Publication of JP7067725B2 publication Critical patent/JP7067725B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524667A 2017-07-17 2018-07-17 Acc阻害剤としての新規な化合物およびそれらの使用 Expired - Fee Related JP7067725B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2017/093106 2017-07-17
CNPCT/CN2017/093106 2017-07-17
PCT/CN2018/095973 WO2019015583A1 (en) 2017-07-17 2018-07-17 NOVEL COMPOUNDS AND THEIR USES AS ACC INHIBITORS

Publications (3)

Publication Number Publication Date
JP2020527175A JP2020527175A (ja) 2020-09-03
JP2020527175A5 true JP2020527175A5 (enExample) 2021-07-26
JP7067725B2 JP7067725B2 (ja) 2022-05-16

Family

ID=65014996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524667A Expired - Fee Related JP7067725B2 (ja) 2017-07-17 2018-07-17 Acc阻害剤としての新規な化合物およびそれらの使用

Country Status (5)

Country Link
US (1) US10995099B2 (enExample)
EP (1) EP3655409B1 (enExample)
JP (1) JP7067725B2 (enExample)
CN (1) CN111201234A (enExample)
WO (2) WO2019015583A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3660023B1 (en) * 2017-07-26 2023-03-08 Nanjing Sanhome Pharmaceutical Co., Ltd. Thienopyrimidinedione compounds as acc inhibitors and use thereof
CN113924303B (zh) 2019-07-02 2023-10-20 广东东阳光药业股份有限公司 具有立体构型的噻吩并嘧啶衍生物及其在药物中的应用
AR119594A1 (es) * 2019-08-09 2021-12-29 Gilead Sciences Inc Derivados de tienopirimidina como inhibidores acc y usos de los mismos
JP7612682B2 (ja) 2019-10-15 2025-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なテトラゾール
CN112778325A (zh) * 2019-11-07 2021-05-11 南京瑞捷医药科技有限公司 一种acc抑制剂及其用途
KR20230087531A (ko) * 2020-10-14 2023-06-16 베링거 인겔하임 인터내셔날 게엠베하 Trpa1 억제제로서 테트라졸 유도체
IL301717B2 (en) * 2020-10-14 2026-05-01 Boehringer Ingelheim Int History of tetrazoles as TRPA1 inhibitors
CN116745299A (zh) * 2021-02-07 2023-09-12 正大天晴药业集团股份有限公司 噻吩并嘧啶衍生物
JP7565457B2 (ja) 2021-04-14 2024-10-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング TRPA1阻害剤としての3H,4H-チエノ-[2,3-d]ピリミジン-4-オン誘導体
CN114409664B (zh) * 2021-12-24 2023-07-18 河北威远生物化工有限公司 一种螺杂环四氢吡喃化合物及其制备方法和应用
CN114815020B (zh) * 2022-04-21 2023-09-22 岭南师范学院 一种高品质因数折射率传感器的设计方法及折射率传感器
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX370976B (es) * 2011-11-11 2020-01-10 Gilead Apollo Llc Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos.
MX360058B (es) * 2012-05-30 2018-10-19 Bayer Cropscience Ag Composiciones que comprenden un agente de control biológico y un insecticida.
EA201591962A1 (ru) 2013-05-10 2016-06-30 Нимбус Аполло, Инк. Ингибиторы акк и их применение
WO2015003879A1 (en) * 2013-07-08 2015-01-15 Syngenta Participations Ag Microbiocidal heterobicylic derivatives
CN105949197A (zh) * 2014-01-29 2016-09-21 苏州晶云药物科技有限公司 依鲁替尼的新晶型及其制备方法
GB201419102D0 (en) * 2014-10-27 2014-12-10 Imp Innovations Ltd Novel compounds
MX2017008844A (es) * 2015-01-09 2018-03-14 Gilead Apollo Llc Terapia de combinacion con inhibidor de acetil-coa carboxilasa (acc) para el tratamiento de enfermedad de higado graso no alcoholico.
CN205115664U (zh) * 2015-10-15 2016-03-30 阳光能源(青海)有限公司 一种用于单晶炉的二次填料装置
CN106137971A (zh) * 2015-11-17 2016-11-23 南京瑞捷医药科技有限公司 一种他克莫司分散体及其缓释组合物及制备方法
US20170166582A1 (en) * 2015-11-25 2017-06-15 Gilead Apollo, Llc Pyrazole acc inhibitors and uses thereof
PL3380479T3 (pl) * 2015-11-25 2023-05-08 Gilead Apollo, Llc Triazolowe inhibitory acc i ich zastosowania
CA3155220C (en) 2016-03-02 2024-01-16 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
CA3137479A1 (en) * 2017-03-03 2018-09-07 Gilead Sciences, Inc. Processes for preparing acc inhibitors and solid forms thereof
WO2018228369A1 (zh) * 2017-06-15 2018-12-20 浙江海正药业股份有限公司 杂芳基并嘧啶酮类衍生物、其制备方法及其在医药上用途
EP3660023B1 (en) * 2017-07-26 2023-03-08 Nanjing Sanhome Pharmaceutical Co., Ltd. Thienopyrimidinedione compounds as acc inhibitors and use thereof

Similar Documents

Publication Publication Date Title
JP2012526728A5 (enExample)
JP2013537203A5 (enExample)
JP2013509392A5 (enExample)
JP2006524222A5 (enExample)
JP2014514286A5 (enExample)
JP2016535732A5 (enExample)
JP2012518634A5 (enExample)
JP2015516420A5 (enExample)
JP2015509535A5 (enExample)
JP2014051526A5 (enExample)
JP2015520140A5 (enExample)
JP2015535839A5 (enExample)
JP2011513410A5 (enExample)
JP2014500265A5 (enExample)
JP2016540742A5 (enExample)
JP2016534134A5 (enExample)
JP2009143956A5 (enExample)
JP2016512505A5 (enExample)
JP2007530698A5 (enExample)
JP2009519249A5 (enExample)
JP2013533253A5 (enExample)
JP2017505293A5 (enExample)
RU2017101829A (ru) Пиразоловые соединения в качестве модуляторов fshr и пути их применения
JP2017538689A5 (enExample)
JP2015536974A5 (enExample)